Clinical Trial Update: Safety and Efficacy of SM934 Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of SM934 versus placebo in adults with active systemic lupus erythematosus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• SM934

Snippet

Sponsor: RenJi Hospital | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED